Ontology highlight
ABSTRACT:
SUBMITTER: Moussa M
PROVIDER: S-EPMC7886109 | biostudies-literature | 2021
REPOSITORIES: biostudies-literature
Moussa Mohamad M Papatsoris Athanasios A Abou Chakra Mohamed M Dellis Athanasios A
Drug design, development and therapy 20210211
Nowadays the therapeutic landscape for advanced and metastatic urothelial carcinoma continues to evolve. The recent regulatory approval of enfortumab vedotin (EV) for the treatment of advanced urothelial cancer confirms the evolving role of antibody-drug conjugates. EV demonstrates a favorable profile in heavily pretreated patients with locally advanced or metastatic urothelial carcinoma. Early survival reports demonstrate a significant antitumor effectiveness along with a rather acceptable safe ...[more]